Senior insider sale
Chief Financial Officer at ESPERION THERAPEUTICS, INC. — senior position signals high conviction
$46.7K
14.38K shares
What this filing means
HALLADAY BENJAMIN plans to sell 14.38K shares of ESPERION THERAPEUTICS, INC. valued at approximately $46.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/17/2025ACC: 0001959173-25-007812
Officer· Chief Financial Officer
Since Nov 2022
14.38K
Shares to sell
$46.7K
Approx. market value
7.34K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
12/15/2025
7.34KTotal acquired7.34K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/15/2025 | Restricted Stock Vesting Compensation | 7.34K | — |
| Total | 7.34K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
7.05K
Market value
$19.8K
9/17/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.34K
Market value
$26.9K
12/17/2025
Total
Units
14.38K
Value
$46.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/17/2025 | 7.05K | $19.8K | — | Completed |
| Planned — Approximate Date | ||||
12/17/2025 | 7.34K | $26.9K | NASDAQ | Planned |
| Total | 14.38K | $46.7K | ||